Journals / Black Sea Journal of Health Science / 2019 / Cilt: 2 - Sayı: 3

Brucellosis: A Retrospective Evaluation of 170 Cases

Pages
60–64
Publication Date
2019-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Laboratory results can help the clinician to identify the complications of this disease, especially osteoarticular complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Brucellosis is an important disease with devastating outcomes in developing countries and may cause complications in many organ systems.
📊
Key Findings & Data:The clinical and laboratory characteristics of 170 cases of brucellosis followed at the Afyon Kocatepe University Faculty of Medicine Infectious Diseases Clinic and Afyonkarahisar State Hospital of Medicine Infectious Diseases Clinic in Turkey, were retrospectively evaluated.
💡
Conclusion & Impact:Laboratory results can help the clinician to identify the complications of this disease, especially osteoarticular complications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Brucellosis · Epidemiology · Clinical finding

Abstract

Brucellosis is an important disease with devastating outcomes in developing countries and may cause complications in many organ systems. The clinical and laboratory characteristics of 170 cases of brucellosis followed at the Afyon Kocatepe University Faculty of Medicine Infectious Diseases Clinic and Afyonkarahisar State Hospital of Medicine Infectious Diseases Clinic in Turkey, were retrospectively evaluated. In our study, total of 170 patients (female, n=74; 43.5%, and male, n=96; 56.5%) with a mean age of 44.12 ± 15.52 years were included. The patients were living in rural areas (n=134; 78.8%) or in the city center (n=36; 21.2%), while 112 (65.9%) patients were raising livestock and 84 patients (49.4%) were consumers of unpasteurized raw milk and dairy products. The most frequent complaints detected in patients with brucellosis include joint pain, fever, weakness, back pain and gastrointestinal symptoms. Fever, arthritis and scrotal swelling were observed more frequently than the others. The standard tube agglutination titer was > 1/160 in 150 (88.2%) patients. Blood cultures have positive results in 68 (59.6%) patients. Complications were detected in 45 patients (26.4%). Osteoarticular system involvement was the most common complication in 33 (19.4%) patients. Other complications were epididymo-orchitis in 9 (5.3%) and depression in 3 (1.8%) patients (Table 2). Sacroileitis was the most frequent osteoarticular involvement which was detected in 13 (7.6%) patients. Other osteoarticular involvements were peripheral monoarthritis in 11 (6.5%), and spondylodiscitis in 9 (5.3%) patients. Increased C-reactive protein (CRP) and high serum transaminase levels were significantly higher in the complication groups. The most frequent drug treatment was rifampicin and doxycyline among different treatment regimens. Brucellosis should be considered in the differential diagnosis of patients who present with fever and osteoarticular symptoms. Laboratory results can help the clinician to identify the complications of this disease, especially osteoarticular complications.

🔖

Cite This Article

TUNAY, H., DEMİRTURK, N., KONYA, P. S., PAMUKCUOGLU, S. (2019). Brucellosis: A Retrospective Evaluation of 170 Cases. Black Sea Journal of Health Science, Cilt: 2 - Sayı: 3, 60–64. https://ajindex.com/articles/745356

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Al Dahouk S, Nöckler K. 2011. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev. Anti Infect. Ther, 9: 833–845.
  2. Ariza J, Bosilkovski M, Cascio A. 2007. Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations. PloS Med, 4: 1872-1878.
  3. Ataman-Hatipoğlu C, Kınklı S, Tulek N, Tekin-Koruk S, Arslan S, Tuncer-Ertem G. 2005. Bir eğitim hastanesinin infeksiyon hastalıkları ve klinik mikrobiyoloji kliniginde izlenen 202 bruselloz olgusunun epidemiyolojik verilerinin irdelenmesi. Klimik Derg, 18: 94–98.
  4. Aygen B, Doğanay M, Sümerkan B, Yıldız O, Kayabas U. 2002. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect, 32: 485–493.
  5. Barua A, Kumar A, D. Tavaselvam et al. 2016. Isolation & characterization of brucella melitensis isolated from patients suspected for human brucellosis in India, Te Indian Journal of Medical Research, 143: 652–658.
  6. Bulut C, Yetkin MA, Yılmaz G, Erdinc FŞ, Hatipoğlu CA, Kınıklı S. 2011. Assessment of the findings on the existence of complications in brucellosis. Turk J Med Sci, 41: 275–282.
  7. Buzgan T, Karahocagil MK, Irmak H. 2010. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis, 14: 469-478.
  8. Calık Ş, Gokengin AD. 2011. Human brucellosis in Turkey: a review of the literature between 1990 and 2009. Turk J Med Sci, 41: 549–555.
  9. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. 2012. Clinical manifestations of human brucellosis: a systematic review and meta-analysis, PLOS Neglected Tropical Diseases, 12: e1929.
  10. Demiroğlu YZ, Turunc T, Alışkan H, Colakoğlu, Arslan H,. 2007. Brucellosis: retrospective evaluation of the clinical, laboratory and epidemiological features in 151 cases. Mikrobiyol Bül, 41: 517–527.
  11. Demirtürk N, Demirdal T, Erben N. 2008. Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment. Trop Doct, 38: 59-62.
  12. Doğanay M, Meşe EA. 2008. Bruselloz. In: Willke Topçu A, Söyletir G, Doğanay M, eds. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. 3. baskı. İstanbul: Nobel Tıp Kitabevleri, p. 897-908.
  13. Erbaydar T, Serpen A, Kurt AÖ. 2012. Hasuder, “Bulaşıcı Hastalıklar”. In: Türkiye Sağlık Raporu. Franco MP, Mulder M, Gilman RH, Smits HL. 2007. Human brucellosis. Lancet Infect Dis, 7: 775–786.
  14. Gonen I, Sozen H, Kaya O, Unal O, Guloğlu G, Akcam FZ. 2014. Brucellosis: e